(Q67402659)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:709214%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

title

Decreased first-pass metabolism of labetalol in chronic liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:709214%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

1 reference

chronic liver disease

0 references

author name string

M. Homeida

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A709214

22 July 2022

L. Jackson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A709214

22 July 2022

C. J. Roberts

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A709214

22 July 2022

language of work or name

English

0 references

publication date

1 October 1978

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:709214%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

14 October 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=709214

22 July 2022

number of pages

3

1 reference

full work available at URL

inferred from page(s)

https://europepmc.org/articles/PMC1608159

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A709214

https://europepmc.org/articles/PMC1608159?pdf=render

22 July 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A709214

22 July 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:709214%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:709214%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

issue

6144

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:709214%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

page(s)

1048-1050

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:709214%20AND%20SRC:MED&resulttype=core&format=json

Relationship between plasma concentrations and pharmacological effects of labetalol

12 September 2019

cites work

1 reference

12 December 2020

Biological determinants of propranolol disposition in man

1 reference

12 December 2020

Bioavailability and first-pass metabolism of oral pentazocine in man

1 reference

12 December 2020

Propranolol disposition in chronic liver disease: a physiological approach

1 reference

12 December 2020

Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent

1 reference

12 December 2020

Metabolism of labetalol by animals and man.

1 reference

12 December 2020

A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol

1 reference

12 December 2020

Determinants of serum antipyrine half-lives in patients with liver disease

1 reference

12 December 2020

Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy

1 reference

12 December 2020

Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs

1 reference

12 December 2020

Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors

1 reference

12 December 2020

Quantitation of portasystemic shunting from the splenic and mesenteric beds in alcoholic liver disease

1 reference

12 December 2020

Combined pharmacokinetic and pharmacodynamic studies on alprenolol and 4-hydroxy-alprenolol in man.

1 reference

12 December 2020

The disposition of propranolol. I. Elimination during oral absorption in man

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.2.6144.1048

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:709214%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:709214%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

1 reference